IMPROVEMENT IN SF-36-DERIVED HEALTH UTILITY SCORE WITH LIRAGLUTIDE 3.0 MG VERSUS PLACEBO OVER 3 YEARS IN PREDIABETES
May 1, 2016, 00:00
10.1016/j.jval.2016.03.996
https://www.valueinhealthjournal.com/article/S1098-3015(16)01064-0/fulltext
Title :
IMPROVEMENT IN SF-36-DERIVED HEALTH UTILITY SCORE WITH LIRAGLUTIDE 3.0 MG VERSUS PLACEBO OVER 3 YEARS IN PREDIABETES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01064-0&doi=10.1016/j.jval.2016.03.996
First page :
A251
Section Title :
Systemic Disorders/Conditions - Patient-Reported Outcomes & Patient Preference Studies
Open access? :
No
Section Order :
931